|Articles|February 25, 2007
Oriana Schwindt
Advertisement
Oriana Schwindt
Associate Editor
Oriana Schwindt worked as a reporter, writer, and researcher at several national publications (among them, BusinessWeek and Entertainment Weekly) before joining the Pharm Exec team as Associate Editor. She holds a BS in Journalism from the Medill School of Journalism at Northwestern University.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
5
